Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00867854 · ClinicalTrials.gov registry record
Treatment De-Intensification and Residual HIV-1 in Youth
A clinical trial of HIV Infections and HIV-1, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 34
- Enrollment target
- 17
- Study locations
NCT00867854: Completed study of HIV Infections and HIV-1, sponsored by University of North Carolina, Chapel Hill.
NCT00867854 is a study of HIV Infections and HIV-1 that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 34 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (92% lower). The trial reports 17 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00867854, a study of HIV Infections and HIV-1, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
- 17
- Study locations
Study Summary
This laboratory-based sub-study of ATN 061 and ATN 071 will examine the effect of early treatment followed by treatment de-intensification to atazanavir/ritonavir (ATV/r) monotherapy on steady-state frequencies of replication-competent CD4+ T cell Human Immunodeficiency Virus (HIV)-1 reservoirs or cell-associated infectivity (CAI) and persistent low-level viremia (LLV), and their contribution to successful long-term control of HIV-1 replication among HIV-1 infected adolescents and young adults.
Conditions Studied
Interventions
- OTHER Blood draw
Study Locations (17)
Florida
- Children's Diagnostic and Teatment Center - Fort Lauderdale
- University of Miami School of Medicine - Miami
- University of South Florida College of Medicine - Tampa
California
- Children's Hospital of Los Angeles - Los Angeles
- University of California at San Francisco - San Francisco
District of Columbia
- Children's National Medical Center - Washington D.C.
- Howard University - IMPAACT Site - Washington D.C.
Illinois
- John Stroger Jr. Hospital of Cook County - Chicago
- Children's Memorial Hospital - Chicago
Maryland
- University of Maryland - Baltimore
- Johns Hopkins University - IMPAACT Site - Baltimore
New York
- Mount Sinai Medical Center - New York
- Montefiore Medical Center - The Bronx
Louisiana
- Tulane Medical Center - New Orleans
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-10 |
What the finished NCT00867854 record still lists
NCT00867854 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT00867854 lists 17 locations in 10 states (Florida, California, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT00867854 about?
NCT00867854 is a clinical study titled "Treatment De-Intensification and Residual HIV-1 in Youth". This laboratory-based sub-study of ATN 061 and ATN 071 will examine the effect of early treatment followed by treatment de-intensification to atazanavir/ritonavir (ATV/r) monotherapy on steady-state frequencies of replication-competent CD4+ T cell Human Immunodeficiency Virus (HIV)-1 reservoirs or c...
What is the current status of trial NCT00867854?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2009-02. Estimated completion is 2011-10.
What conditions does trial NCT00867854 study?
This clinical trial studies the following conditions: HIV Infections, HIV-1.
What interventions are being tested in trial NCT00867854?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT00867854?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00867854 being conducted?
This trial has 17 study locations across California, District of Columbia, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00867854's enrollment target sits among peer trials
34 416th of 542 higher than 127 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia